NASDAQ:IKT | News | Inhibikase Therapeutics, Inc.

IKT News

Official issuer or fund updates, exact SEC current reports, and large established publisher coverage, newest first. Every lawfully retained item remains in the corpus; each public page contains at most 100 rows. Headlines open the exact source; summaries are concise descriptions and not investment recommendations. Captured 2026-08-31.

DateTypePublisherHeadlineSummary
2026-08-26Current reportSEC filingInhibikase Therapeutics, Inc. filed Form 8-KInhibikase Therapeutics, Inc. filed Form 8-K covering items 4.01,9.01.
2026-08-11Current reportSEC filingInhibikase Therapeutics, Inc. filed Form 8-KInhibikase Therapeutics, Inc. filed Form 8-K covering items 2.02,9.01.
2026-07-29Current reportSEC filingInhibikase Therapeutics, Inc. filed Form 8-KInhibikase Therapeutics, Inc. filed Form 8-K covering items 3.02,9.01.
2026-07-23Current reportSEC filingInhibikase Therapeutics, Inc. filed Form 8-KInhibikase Therapeutics, Inc. filed Form 8-K covering items 7.01,9.01.
2026-07-14Current reportSEC filingInhibikase Therapeutics, Inc. filed Form 8-KInhibikase Therapeutics, Inc. filed Form 8-K covering items 8.01,9.01.
2026-06-29Current reportSEC filingInhibikase Therapeutics, Inc. filed Form 8-KInhibikase Therapeutics, Inc. filed Form 8-K covering items 5.02,5.03,5.07,9.01.
2026-05-12Current reportSEC filingInhibikase Therapeutics, Inc. filed Form 8-KInhibikase Therapeutics, Inc. filed Form 8-K covering items 2.02,9.01.
2026-04-07Current reportSEC filingInhibikase Therapeutics, Inc. filed Form 8-KInhibikase Therapeutics, Inc. filed Form 8-K covering items 7.01,9.01.
2026-03-26Current reportSEC filingInhibikase Therapeutics, Inc. filed Form 8-KInhibikase Therapeutics, Inc. filed Form 8-K covering items 2.02,9.01.
2025-12-19Current reportSEC filingInhibikase Therapeutics, Inc. filed Form 8-KInhibikase Therapeutics, Inc. filed Form 8-K covering items 8.01,9.01.
2025-11-21Current reportSEC filingInhibikase Therapeutics, Inc. filed Form 8-KInhibikase Therapeutics, Inc. filed Form 8-K covering items 1.01,8.01,9.01.
2025-11-20Current reportSEC filingInhibikase Therapeutics, Inc. filed Form 8-KInhibikase Therapeutics, Inc. filed Form 8-K covering items 8.01,9.01.
2025-11-14Current reportSEC filingInhibikase Therapeutics, Inc. filed Form 8-KInhibikase Therapeutics, Inc. filed Form 8-K covering items 2.02,9.01.
2025-08-14Current reportSEC filingInhibikase Therapeutics, Inc. filed Form 8-KInhibikase Therapeutics, Inc. filed Form 8-K covering items 2.02,7.01,9.01.
2025-06-30Current reportSEC filingInhibikase Therapeutics, Inc. filed Form 8-KInhibikase Therapeutics, Inc. filed Form 8-K covering items 5.07.
2025-05-14Current reportSEC filingInhibikase Therapeutics, Inc. filed Form 8-KInhibikase Therapeutics, Inc. filed Form 8-K covering items 2.02,9.01.
2025-04-14Current reportSEC filingInhibikase Therapeutics, Inc. filed Form 8-KInhibikase Therapeutics, Inc. filed Form 8-K covering items 5.02,7.01,9.01.
2025-03-27Current reportSEC filingInhibikase Therapeutics, Inc. filed Form 8-KInhibikase Therapeutics, Inc. filed Form 8-K covering items 2.02,9.01.
2025-02-24Current reportSEC filingInhibikase Therapeutics, Inc. filed Form 8-KInhibikase Therapeutics, Inc. filed Form 8-K covering items 1.01,3.02,5.02,7.01,9.01.
2025-02-18Current reportSEC filingInhibikase Therapeutics, Inc. filed Form 8-KInhibikase Therapeutics, Inc. filed Form 8-K covering items 5.02,7.01,9.01.
2025-01-29Current reportSEC filingInhibikase Therapeutics, Inc. filed Form 8-KInhibikase Therapeutics, Inc. filed Form 8-K covering items 8.01.
2025-01-06Current reportSEC filingInhibikase Therapeutics, Inc. filed Form 8-KInhibikase Therapeutics, Inc. filed Form 8-K covering items 5.03,5.07,9.01.
2024-12-05Current reportSEC filingInhibikase Therapeutics, Inc. filed Form 8-KInhibikase Therapeutics, Inc. filed Form 8-K covering items 1.02.
2024-10-22Current reportSEC filingInhibikase Therapeutics, Inc. filed Form 8-KInhibikase Therapeutics, Inc. filed Form 8-K covering items 1.01,5.02,7.01,9.01.
2024-10-10Current reportSEC filingInhibikase Therapeutics, Inc. filed Form 8-KInhibikase Therapeutics, Inc. filed Form 8-K covering items 1.01,3.02,5.02,7.01,8.01,9.01.
2024-10-09Current reportSEC filingInhibikase Therapeutics, Inc. filed Form 8-KInhibikase Therapeutics, Inc. filed Form 8-K covering items 7.01,9.01.
2024-08-06Current reportSEC filingInhibikase Therapeutics, Inc. filed Form 8-KInhibikase Therapeutics, Inc. filed Form 8-K covering items 5.07.
2024-06-10Current reportSEC filingInhibikase Therapeutics, Inc. filed Form 8-KInhibikase Therapeutics, Inc. filed Form 8-K covering items 5.07.
2024-05-20Current reportSEC filingInhibikase Therapeutics, Inc. filed Form 8-KInhibikase Therapeutics, Inc. filed Form 8-K covering items 1.01,3.02,7.01,9.01.
2024-04-30Current reportSEC filingInhibikase Therapeutics, Inc. filed Form 8-KInhibikase Therapeutics, Inc. filed Form 8-K covering items 7.01,8.01,9.01.
2024-04-19Current reportSEC filingInhibikase Therapeutics, Inc. filed Form 8-KInhibikase Therapeutics, Inc. filed Form 8-K covering items 7.01,9.01.
2024-04-02Current reportSEC filingInhibikase Therapeutics, Inc. filed Form 8-K/AInhibikase Therapeutics, Inc. filed Form 8-K/A covering items 5.02,9.01.
2024-02-07Current reportSEC filingInhibikase Therapeutics, Inc. filed Form 8-KInhibikase Therapeutics, Inc. filed Form 8-K covering items 8.01,9.01.
2024-02-01Current reportSEC filingInhibikase Therapeutics, Inc. filed Form 8-KInhibikase Therapeutics, Inc. filed Form 8-K covering items 1.01,9.01.
2024-01-16Current reportSEC filingInhibikase Therapeutics, Inc. filed Form 8-KInhibikase Therapeutics, Inc. filed Form 8-K covering items 5.02,9.01.
2023-09-20Current reportSEC filingInhibikase Therapeutics, Inc. filed Form 8-KInhibikase Therapeutics, Inc. filed Form 8-K covering items 7.01,9.01.
2023-07-17Current reportSEC filingInhibikase Therapeutics, Inc. filed Form 8-KInhibikase Therapeutics, Inc. filed Form 8-K covering items 8.01,9.01.
2023-06-29Current reportSEC filingInhibikase Therapeutics, Inc. filed Form 8-KInhibikase Therapeutics, Inc. filed Form 8-K covering items 3.03,5.03,7.01,9.01.
2023-06-28Current reportSEC filingInhibikase Therapeutics, Inc. filed Form 8-KInhibikase Therapeutics, Inc. filed Form 8-K covering items 5.07.
2023-03-22Current reportSEC filingInhibikase Therapeutics, Inc. filed Form 8-KInhibikase Therapeutics, Inc. filed Form 8-K covering items 7.01,9.01.
2023-03-13Current reportSEC filingInhibikase Therapeutics, Inc. filed Form 8-KInhibikase Therapeutics, Inc. filed Form 8-K covering items 8.01.
2023-03-06Current reportSEC filingInhibikase Therapeutics, Inc. filed Form 8-KInhibikase Therapeutics, Inc. filed Form 8-K covering items 5.02.
2023-01-26Current reportSEC filingInhibikase Therapeutics, Inc. filed Form 8-KInhibikase Therapeutics, Inc. filed Form 8-K covering items 1.01,1.02,3.02,7.01,9.01.
2023-01-25Current reportSEC filingInhibikase Therapeutics, Inc. filed Form 8-KInhibikase Therapeutics, Inc. filed Form 8-K covering items 8.01,9.01.
2023-01-24Current reportSEC filingInhibikase Therapeutics, Inc. filed Form 8-KInhibikase Therapeutics, Inc. filed Form 8-K covering items 3.01.
2022-11-17Current reportSEC filingInhibikase Therapeutics, Inc. filed Form 8-KInhibikase Therapeutics, Inc. filed Form 8-K covering items 2.02,9.01.
2022-11-07Current reportSEC filingInhibikase Therapeutics, Inc. filed Form 8-KInhibikase Therapeutics, Inc. filed Form 8-K covering items 8.01,9.01.
2022-09-16Current reportSEC filingInhibikase Therapeutics, Inc. filed Form 8-KInhibikase Therapeutics, Inc. filed Form 8-K covering items 7.01,9.01.
2022-09-01Current reportSEC filingInhibikase Therapeutics, Inc. filed Form 8-KInhibikase Therapeutics, Inc. filed Form 8-K covering items 5.02,7.01,9.01.
2022-08-15Current reportSEC filingInhibikase Therapeutics, Inc. filed Form 8-KInhibikase Therapeutics, Inc. filed Form 8-K covering items 7.01,9.01.
2022-07-29Current reportSEC filingInhibikase Therapeutics, Inc. filed Form 8-KInhibikase Therapeutics, Inc. filed Form 8-K covering items 3.01.
2022-06-29Current reportSEC filingInhibikase Therapeutics, Inc. filed Form 8-KInhibikase Therapeutics, Inc. filed Form 8-K covering items 5.07.
2022-05-17Current reportSEC filingInhibikase Therapeutics, Inc. filed Form 8-KInhibikase Therapeutics, Inc. filed Form 8-K covering items 1.01,9.01.
2022-04-21Current reportSEC filingInhibikase Therapeutics, Inc. filed Form 8-KInhibikase Therapeutics, Inc. filed Form 8-K covering items 7.01,9.01.
2022-03-24Current reportSEC filingInhibikase Therapeutics, Inc. filed Form 8-KInhibikase Therapeutics, Inc. filed Form 8-K covering items 7.01,9.01.
2022-03-21Current reportSEC filingInhibikase Therapeutics, Inc. filed Form 8-K/AInhibikase Therapeutics, Inc. filed Form 8-K/A covering items 5.02,9.01.
2022-03-08Current reportSEC filingInhibikase Therapeutics, Inc. filed Form 8-KInhibikase Therapeutics, Inc. filed Form 8-K covering items 5.02,9.01.
2022-01-20Current reportSEC filingInhibikase Therapeutics, Inc. filed Form 8-KInhibikase Therapeutics, Inc. filed Form 8-K covering items 7.01,9.01.
2021-10-19Current reportSEC filingInhibikase Therapeutics, Inc. filed Form 8-KInhibikase Therapeutics, Inc. filed Form 8-K covering items 7.01,9.01.
2021-09-08Current reportSEC filingInhibikase Therapeutics, Inc. filed Form 8-KInhibikase Therapeutics, Inc. filed Form 8-K covering items 8.01.
2021-08-17Current reportSEC filingInhibikase Therapeutics, Inc. filed Form 8-KInhibikase Therapeutics, Inc. filed Form 8-K covering items 7.01,9.01.
2021-06-29Current reportSEC filingInhibikase Therapeutics, Inc. filed Form 8-KInhibikase Therapeutics, Inc. filed Form 8-K covering items 5.07.
2021-06-21Current reportSEC filingInhibikase Therapeutics, Inc. filed Form 8-KInhibikase Therapeutics, Inc. filed Form 8-K covering items 7.01,9.01.
2021-06-16Current reportSEC filingInhibikase Therapeutics, Inc. filed Form 8-KInhibikase Therapeutics, Inc. filed Form 8-K covering items 1.01,9.01.
2021-06-01Current reportSEC filingInhibikase Therapeutics, Inc. filed Form 8-KInhibikase Therapeutics, Inc. filed Form 8-K covering items 7.01,9.01.
2021-04-01Current reportSEC filingInhibikase Therapeutics, Inc. filed Form 8-KInhibikase Therapeutics, Inc. filed Form 8-K covering items 2.02,9.01.
2021-02-08Current reportSEC filingInhibikase Therapeutics, Inc. filed Form 8-KInhibikase Therapeutics, Inc. filed Form 8-K covering items 7.01,9.01.
2020-12-29Current reportSEC filingInhibikase Therapeutics, Inc. filed Form 8-KInhibikase Therapeutics, Inc. filed Form 8-K covering items 3.02,5.03,8.01,9.01.